Skip to main content
SpringerLink
Log in

Lung Cancer

  • Chapter
Geriatric Medicine

  • 566 Accesses

Conclusions

The epidemic of lung cancer continues in the United States, and the elderly remain the major target. Despite a decline in smoking by men in the United States, antismoking campaigns have not been successful in preventing teenage smoking or in decreasing the percent of women who smoke, so the epidemic will continue.

Despite the high mortality of lung cancer, however, long-term survival is now possible, not only for surgically resected patients but also for some patients with stage III non-small cell lung cancer or limited-stage small cell lung cancer. Even in advanced disease, significant improvement have been made by the use of chemotherapy and supportive care in appropriate patients. Elderly patients with lung cancer deserve careful evaluation of treatment options in a multidisciplinary setting.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 299.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 379.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ginsberg RJ, Vokes EE, Rosenzweig K. Cancer of the lung. In: Devita VT, Hellman S, Rosenberg SA, eds. Cancer Principles and Practice of Oncology, 6th Ed. Philadelphia: Lippincott Williams & Wilkins; 2001:925–983.

    Google Scholar 

  2. Yancik R, Reis LA. Cancer in older persons-magnitude of the problem. How do we apply what we know? Cancer. 1994; 74(suppl 1):1995–2003.

    PubMed  CAS  Google Scholar 

  3. Doll R, Hill AB. Lung cancer and other causes of death related to smoking: a second report on the mortality of British doctors. Br Med J. 1956;2:1071–1081.

    Article  PubMed  CAS  Google Scholar 

  4. Pathak DR, Samet JM, Humble CG, et al. Determinants of lung cancer risk in cigarette smokers in New Mexico. JNCI. 1994;76:597–604.

    Google Scholar 

  5. Crawford J, O’Rourke MA, Cohen HJ. Age factors in the management of lung cancer. In: Yancik R, Yates JW, eds. Cancer in the Elderly. New York: Springer; 1989:177–203.

    Google Scholar 

  6. Orleans TC, Jepson C, Resch N, et al. Quitting motives and barriers among older smokers; the 1987 Adult Use of Tobacco Survey revisited. Cancer (Suppl). 1994;74:2055–2061.

    CAS  Google Scholar 

  7. Halpern M, Gillespie B, Warner K. Patters of absolute risk of lung cancer: mortality in former smokers. JNCI. 1993; 85:457–464.

    PubMed  CAS  Google Scholar 

  8. Rimer BK, Orleans TC. Tailoring smoking cessation for older adults. Cancer (Suppl). 1994;74:2051–2054.

    CAS  Google Scholar 

  9. DeMaria LC, Cohen HJ. Characteristics of lung cancer in the elderly patients. J Gerontol. 1987;42:540–545.

    PubMed  Google Scholar 

  10. O’Rourke MA, Feussner JR, Ferge P, et al. Age trends of lung cancer at diagnosis. JAMA. 1987;258:921–926.

    Article  PubMed  CAS  Google Scholar 

  11. Rimer BK, Heman D, Crawford J, et al. Lung cancer in North Carolina. NC Med J. 1993;54:334–341.

    CAS  Google Scholar 

  12. Henschke C, McCauley D, Yankelevitz D, et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet. 1999;354:99–105.

    Article  PubMed  CAS  Google Scholar 

  13. Vaporciyan AA, Nesbitt JC, Lee JS, et al. Cancer of the Lung. In: Bast RC, Kufe DW, Pollock RE, Weichselbaum RR, Holland JF, Frie E, eds. Cancer Medicine, 5th ed. Ontario: BC Decker, Inc. 2000:1227–1292.

    Google Scholar 

  14. Ershler EB, Socinski MA, Greene CJ. Bronchogenic cancer, metastases and aging. J Am Geriatr Soc. 1994;31:673–676.

    Google Scholar 

  15. Luke WP, Pearson FG, Todd TFJ, et al. Prospective evaluation of medianstinoscopy for assessment of carcinoma of the lung. J Thorac Cardiovasc Surg. 1986;91:53–56.

    PubMed  CAS  Google Scholar 

  16. McKenna RJ. Clinical aspects cancer in the elderly. Treatment decisions, treatment choices, and follow up. Cancer. 1994;74:2107–2117.

    PubMed  Google Scholar 

  17. Walsh SJ, Begg CB, Carbone PP. Cancer chemotherapy in the elderly. Semin Oncol. 1989;16:66–75.

    PubMed  CAS  Google Scholar 

  18. Massard G, Moog R, Wihlm JM, et al. Bronchogenic cancer in the elderly: operative risk and long-term prognosis. Thorac Cardiovasc Surg. 1996;44:40–45.

    Article  PubMed  CAS  Google Scholar 

  19. PORT Meta-analysis Trialists Group. Postoperative radiotherapy in non-small cell lung cancer: systemic review and meta-analysis of individual patient data from nine randomized controlled trials. Lancet. 1998;352:257–263.

    Article  Google Scholar 

  20. Rosell R, Gomez-Codina J, Cmaps C, et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer. N Engl J Med. 1994;330;153–158.

    Google Scholar 

  21. Roth J, Rossella F, Komaki R, et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable non-small cell lung cancer. JNCI. 1994;86:673–680.

    PubMed  CAS  Google Scholar 

  22. Crocker I, Prosnitz L. Radiation therapy of the elderly. In: Clinics in Geriatric Medicine, vol III. Philadelphia: Saunders; 1987:473–478.

    Google Scholar 

  23. Dillman RO, Seagren SL, Propert KJ, et al. A randomized trial of induction chemotherapy plus high dose radiation versus radiation alone in stage III non small cell lung cancer. N Engl J Med. 1990;323:989–990.

    Article  Google Scholar 

  24. Dillman R, Herndon J, Seagren S, Eaton W, Green M. Improved survival in Stage III non-small cell lung cancer: seven-year follow-up of Cancer and Leukemia Group B (CALGB) 8433 Trial. JNCI. 1996;88:1210–1215.

    PubMed  CAS  Google Scholar 

  25. Schaake-Koning C, van den Bogert W, Dalesio O, et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer. N Engl J Med. 1992; 326:524–530.

    Article  PubMed  CAS  Google Scholar 

  26. Souquet PJ, Chauvin F, Boissel R, et al. Polychemotherapy in advanced non-small cell lung cancer: a metaanalysis. Lancet. 1993;342:19–21.

    Article  PubMed  CAS  Google Scholar 

  27. Grilli R, Oxman A, Julian JJ. Chemotherapy for advanced non-small cell lung cancer: how much benefit is enough? J Clin Oncol. 1993;11:1966–1972.

    Google Scholar 

  28. Albain KS, Crowley JJ, LeBlanc M, et al. Survival determinants in extensive stage non-small cell lung cancer: The Southwest Oncology Group experience. J Clin Oncol. 1991; 9:1618–1626.

    PubMed  CAS  Google Scholar 

  29. Giovanazzi-Bannon S, Rademake A, Lai G, et al. Treatment tolerance of elderly cancer patients entered onto Phase II clinical trials: an Illinois cancer center study. J Clin Oncol. 1994;12:2447–2452.

    PubMed  CAS  Google Scholar 

  30. Johnson DH, Zhu J, Schiller J, et al. E1494: a randomized phase III trial in metastatic non-small cell lung cancer (NSCLC)-outcome of performance status 2 patients: an Eastern Cooperative Group Trial (ECOG). Proceedings American Society of Clinical Oncology. 1999;18:461a [abstract 1779].

    Google Scholar 

  31. The Elderly Lung Cancer Vinorelbine Italian Study Group. Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small cell lung cancer. JNCI. 1999;91:66–72.

    Article  Google Scholar 

  32. LeChevalier T, Brisgand D, Douillard J-Y, et al. Randomized study of vinorelbine and cisplatin alone in advanced non-small cell lung cancer: results of a European multicenter trial including 612 patients. J Clin Oncol. 1994;12:360–367.

    CAS  Google Scholar 

  33. Shepherd FA, Abratt RP, Anderson H, et al. Gemcitabine in the treatment of elderly patients with advanced non-small cell lung cancer. Semin Oncol. 1997;24(2):S7–S50.

    PubMed  CAS  Google Scholar 

  34. Fidias P, Supko J, Martins R, et al. A phase II clinical and pharmacokinetic study of weekly paclitaxel in elderly patients with non-small cell lung cancer. Lung Cancer. 2000;29(1):57 [abstract 184].

    Article  Google Scholar 

  35. Turrisi A, Kim K, Blum R, et al. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med. 1999;340:265–271.

    Article  PubMed  CAS  Google Scholar 

  36. Komaki R, Meyers C, Shin D, et al. Evaluation of cognitive function in patients with limited small cell lung cancer prior to and shortly following prophylactic cranial irradiation. Int J Radiat Oncol Biol Phys. 1995;33:179–182.

    Article  PubMed  CAS  Google Scholar 

  37. Lishner M, Feld R, Payne D, et al. Late neurological complications after prophylactic cranial irradiation in patients with small-cell lung cancer: the Toronto Experience. J Clin Oncol. 1990;8:215–221.

    PubMed  CAS  Google Scholar 

  38. Auperin A, Arriagada R, Pignon J, et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. N Engl J Med. 1999;314:476–484.

    Article  Google Scholar 

  39. Shepherd FA, Amdemicheal E, Evans WK. Treatment of small cell lung cancer in the elderly. J Am Geriatr Soc. 1994; 42:64–70.

    PubMed  CAS  Google Scholar 

  40. Foley KM. Supportive care and the quality of life in the cancer patient. In: Devita VT, Hellman S, Rosenberg SA, eds. Cancer Principles and Practice of Oncology, 4th Ed. Philadelphia: Lippincott; 1993:2417–2448.

    Google Scholar 

  41. Daly JM, Torosian MH. Nutritional support. In: Devita VT, Hellman S, Rosenberg SA, eds. Cancer Principles and Practice of Oncology, 4th Ed. Philadelphia: Lippincott;1993: 2480–2501.

    Google Scholar 

  42. Demetri G, Kris M, Wade J, Degos L, Cella D, for the Procrit Study Group. Quality-of-life benefit in chemotherapy patients treated with Epoetin Alfa is independent of disease response or tumor type: results from a prospective community oncology study. J Clin Oncol. 1998;16: 3412–3425.

    PubMed  CAS  Google Scholar 

  43. Hopwood P, Stephens RJ, Fletche I, Lee A. The impact of depression on quality of life and survival in patients with inoperable lung cancer. Lung Cancer. 2000;29(1):272 [abstract 931].

    Article  Google Scholar 

Download references

Authors
  1. Eric B. Haura
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Susan A. Blackwell
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jeffrey Crawford
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag New York, Inc.

About this chapter

Cite this chapter

Haura, E.B., Blackwell, S.A., Crawford, J. (2003). Lung Cancer. In: Geriatric Medicine. Springer, New York, NY. https://doi.org/10.1007/0-387-22621-4_36

Download citation

  • DOI: https://doi.org/10.1007/0-387-22621-4_36

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-95514-8

  • Online ISBN: 978-0-387-22621-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation